OBI Pharma, Inc. (TPEX:4174)

OBI Pharma Revenue

OBI Pharma had revenue of 10.52M TWD in the quarter ending September 30, 2025, a decrease of -54.21%. This brings the company's revenue in the last twelve months to 49.29M, down -29.13% year-over-year. In the year 2024, OBI Pharma had annual revenue of 62.68M with 50.85% growth.

• Revenue (ttm): 49.29M
• Revenue Growth: -29.13%
• P/S Ratio: 134.72
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 6.64B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	62.68M	21.13M	50.85%
Dec 31, 2023	41.55M	36.84M	781.96%
Dec 31, 2022	4.71M	-14.06M	-74.90%
Dec 31, 2021	18.77M	-122.11M	-86.68%
Dec 31, 2020	140.89M	135.30M	2,422.13%